Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tutt

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|September 1, 1984
Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: a guide for immunotherapyF K Stevenson, M J Glennie, D M Johnston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibodyAlison L Tutt, Lyn O'Brien, Akmal Hussain, et al.
Molecular Immunology|November 1, 1991
Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectorsJ Greenman, A L Tutt, A J George, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1991
CD2 antigen mediated activation of the guanine nucleotide binding proteins p21ras in human T lymphocytesJ D Graves, J Downward, S Rayter, et al.
Blood|November 9, 2000
Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphomaJ Honeychurch, A L Tutt, T Valerius, et al.
Journal of Neuro-Oncology|July 1, 1992
The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructsS K Obukhov, M J Gennie, A L Tutt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2011
Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegenerationKatie Lunnon, Jessica L Teeling, Alison L Tutt, et al.
Blood|March 1, 1987
Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytesM Wrightham, A L Tutt, M J Glennie, et al.
Blood|October 24, 2015
Anti-mouse FcγRIV antibody 9E9 also blocks FcγRIII in vivoThomas R W Tipton, C Ian Mockridge, Ruth R French, et al.
Journal of Immunological Methods|June 16, 2010
Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjectsG Hampson, T H Ward, J Cummings, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|September 1, 1984
Consumption of monoclonal anti-idiotypic antibody by neoplastic B lymphocytes: a guide for immunotherapyF K Stevenson, M J Glennie, D M Johnston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
T cell immunity to lymphoma following treatment with anti-CD40 monoclonal antibodyAlison L Tutt, Lyn O'Brien, Akmal Hussain, et al.
Molecular Immunology|November 1, 1991
Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectorsJ Greenman, A L Tutt, A J George, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1991
CD2 antigen mediated activation of the guanine nucleotide binding proteins p21ras in human T lymphocytesJ D Graves, J Downward, S Rayter, et al.
Blood|November 9, 2000
Therapeutic efficacy of FcgammaRI/CD64-directed bispecific antibodies in B-cell lymphomaJ Honeychurch, A L Tutt, T Valerius, et al.
Journal of Neuro-Oncology|July 1, 1992
The cytotoxic action of lymphokine activated killer cells upon the human glioma cell line U251 is stimulated by bispecific monoclonal antibody (MoAb) constructsS K Obukhov, M J Gennie, A L Tutt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2011
Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegenerationKatie Lunnon, Jessica L Teeling, Alison L Tutt, et al.
Blood|March 1, 1987
Monoclonal anti-light chain idiotype as a tumor-specific probe for human neoplastic B lymphocytesM Wrightham, A L Tutt, M J Glennie, et al.
Blood|October 24, 2015
Anti-mouse FcγRIV antibody 9E9 also blocks FcγRIII in vivoThomas R W Tipton, C Ian Mockridge, Ruth R French, et al.
Journal of Immunological Methods|June 16, 2010
Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjectsG Hampson, T H Ward, J Cummings, et al.
Pageof 6